Governed by Design: Embedding Compliance Into AI From Day One
Post Summary
AI compliance in healthcare isn't optional - it starts on day one. With fines for non-compliance projected to reach $19 billion by 2024 and 230+ regulations updated daily, organizations can't afford to treat governance as an afterthought. Building compliance into AI systems from the start ensures patient safety, avoids costly retrofits, and establishes trust with regulators, investors, and patients.
Key takeaways:
- Regulations: HIPAA, NIST, HITRUST, and state laws like California’s AB 489 and Colorado’s SB 24-205 enforce strict standards for AI in healthcare.
- Risks: Mismanaged AI outputs can lead to clinical errors, data breaches, and fines up to $2.1 million annually for HIPAA violations.
- Solutions: Embed compliance in AI development phases - planning, data handling, deployment, and continuous monitoring.
- Tools and Practices: Use encryption (AES-256, TLS 1.3), immutable audit logs, and tiered oversight for high-risk decisions. Leverage frameworks like ISO/IEC 42001 for ongoing compliance.
Compliance isn't just about avoiding penalties - it's about creating systems that are safe, reliable, and ready for future challenges.
Governance, Compliance, and Risk Management for Healthcare AI Agents
sbb-itb-535baee
Healthcare Regulations That Apply to AI Systems
AI in healthcare operates within a complex web of U.S. regulations. The moment patient data is involved, multiple federal and state laws come into play. Navigating these overlapping frameworks is essential to avoid hefty penalties, which can reach $2.1 million annually for HIPAA violations alone [4]. Addressing compliance from the outset is far more effective than trying to fix issues later.
HIPAA is the cornerstone of healthcare data protection, but it’s far from the only regulation AI developers need to consider. Frameworks like the NIST Cybersecurity Framework and HITRUST CSF provide technical guidance for risk management. Meanwhile, state laws, such as California’s AB 489 and Colorado’s SB 24-205, add layers of requirements, including transparency and bias testing [2][7]. Treating HIPAA as the only standard is a risky approach, as state and federal regulators, as well as the FDA, can impose additional rules.
The regulatory environment is evolving quickly. For instance, the FDA has already authorized over 1,000 AI-enabled medical devices under its Software as a Medical Device (SaMD) classification [5].
AI systems often need to comply with multiple frameworks simultaneously. For example, a single AI documentation tool might need to meet HIPAA, NIST, and state-specific requirements, like California’s "clinical camouflage" rules [2][4][7]. This creates a challenging compliance matrix that requires careful planning from the very beginning.
The following sections break down the three main pillars of healthcare AI compliance: HIPAA’s data protection rules, the technical guidelines provided by NIST and HITRUST, and the growing influence of state privacy laws.
HIPAA Requirements for AI Systems
HIPAA applies equally to data processed by humans and algorithms. The Privacy Rule enforces the "minimum necessary" standard, ensuring AI models only access essential patient data during training [4][5]. Meanwhile, the Security Rule requires safeguards like encryption, access controls, and audit logs to protect electronic PHI (ePHI) [4][5].
AI vendors working with PHI must sign Business Associate Agreements (BAAs) that address risks such as model training and data retention. As Jennifer Walsh, Chief Compliance Officer at Health1st AI, states:
"Any vendor unwilling to sign a BAA cannot be used with PHI, period" [3].
Some major AI providers, like OpenAI and Anthropic, only offer BAAs for Enterprise-tier accounts, leaving smaller users without this critical protection [4][2].
A common misconception is that de-identifying data exempts organizations from HIPAA. This is only true if strict de-identification methods are followed. The Safe Harbor method requires removing all 18 specific identifiers, while Expert Determination involves a statistician certifying that re-identification risk is below 0.05% [3]. Failure to comply can result in significant fines, as one hospital discovered when it paid $2.3 million after a combination of ZIP codes, ages, and diagnoses allowed patient re-identification [3].
HIPAA also mandates 6-year retention of documentation such as audit logs and risk assessments [4][5]. Breach notifications for incidents affecting 500 or more individuals must be reported to HHS within 60 days of discovery [4][5]. This means AI logging systems must capture not only user access details but also the content of AI prompts and responses involving PHI [4][2].
| AI Provider | BAA Available | Covered Products (as of 2026) |
|---|---|---|
| Microsoft Azure | Yes | Azure OpenAI (GPT-5.2, Whisper), Cognitive Services [4] |
| AWS | Yes | Amazon Bedrock (Claude, Llama, Titan), SageMaker [4][2] |
| Google Cloud | Yes | Vertex AI, Gemini models, Healthcare API [4][2] |
| OpenAI | Enterprise Only | ChatGPT Enterprise, API (Enterprise tier) [4][2] |
| Anthropic | Enterprise Only | Claude API (via direct sales agreements) [4][2] |
HIPAA forms the baseline for compliance, but technical frameworks like NIST and HITRUST are essential for operationalizing these requirements.
NIST Cybersecurity Framework and HITRUST CSF
HIPAA outlines what to protect, while NIST and HITRUST focus on how to protect it. The NIST AI Risk Management Framework is widely used in healthcare to address AI-specific risks, emphasizing seven key characteristics: Safe, Secure/Resilient, Explainable, Privacy-enhanced, Fair, Accountable, and Reliable [2][6].
HITRUST CSF translates these principles into actionable controls, ensuring vendors meet both regulatory and enterprise security standards [3][4]. It maps HIPAA requirements to specific steps and provides an audit trail that satisfies regulators. As Joe Braidwood, CEO of GLACIS, explains:
"There is no 'HIPAA certified AI.' HIPAA compliance is not a product attribute - it's an operational state" [4].
What some vendors call "HIPAA certification" is typically a third-party audit based on frameworks like HITRUST CSF or SOC 2 Type II.
These frameworks also require local validation of AI systems to prove they meet their intended use. This includes testing for security resilience, preventing misuse, and planning for secure decommissioning. AI systems must operate under risk-based oversight, where low-risk tasks may run autonomously, but high-risk decisions, like diagnoses, require human review [2].
NIST highlights AI-specific threats that traditional HIPAA risk assessments might overlook, such as prompt injection (manipulative inputs), model inversion (extracting training data), and hallucinations that compromise PHI accuracy [5][6]. Annual security risk analyses must address these threats, capturing metadata for every AI decision, including model version, input hashes, confidence scores, and reviewer identity [2].
While federal standards set the groundwork, state laws introduce additional layers of complexity.
State Privacy Laws That Affect Healthcare AI
States are moving faster than federal regulators, creating a patchwork of rules that often go beyond HIPAA. California’s AB 489 requires AI systems to disclose their artificial nature at the start of interactions and bans "Clinical Camouflage" practices. For example, AI avatars cannot wear clinical attire unless clearly labeled as virtual assistants, with at least 20% of the image’s surface area marked accordingly [7].
Colorado’s SB 24-205, effective February 2026, mandates algorithmic bias testing and impact assessments for "high-risk" AI systems [2][3]. Both California and Colorado grant patients the right to opt out of automated decision-making for significant healthcare decisions, exceeding HIPAA’s provisions [2]. California’s Attorney General has even started using automated tools to identify patient portals that fail to disclose AI usage [7].
Non-compliance can be costly. Under the California Confidentiality of Medical Information Act (CMIA), fines range from $2,500 for negligent disclosures to $250,000 for willful violations, including AI-related data errors [7]. However, California’s AB 3030 offers some relief by allowing a "human-in-the-loop safe harbor." If a licensed professional reviews and approves generative AI outputs, certain requirements are relaxed.
How to Build Compliance Into Each Stage of AI Development
Four-Stage Framework for Embedding Compliance into Healthcare AI Development
When it comes to AI development, weaving compliance into every stage is not just a good idea - it’s essential. Trying to fix compliance issues after development can lead to costly retrofits. A smarter strategy is to embed compliance considerations right from the beginning, starting with the planning phase and continuing through deployment and ongoing monitoring.
This approach means asking key compliance questions before any code is written. For example, will the AI handle any of the 18 HIPAA identifiers? If so, you’ll need a de-identification strategy early on. Similarly, does your cloud provider offer a Business Associate Agreement (BAA) for the tier you’re using? These decisions have long-lasting effects on your system’s architecture.
As Jeff Ward from Aprio emphasizes:
"Effective compliance isn't about checking boxes when auditors arrive - it's about building audit-ready processes from day one." [1]
Let’s break down how compliance can be integrated into planning, data handling, and deployment to avoid costly mistakes and align with HIPAA, NIST, and state regulations.
Planning and Risk Assessment
The planning phase is where you lay the groundwork for compliance. Start by determining whether your AI will process protected health information (PHI). If it does, verifying your vendor’s ability to comply with HIPAA is critical. For instance, cloud providers must sign a BAA if PHI data is involved. Some vendors only offer BAAs for higher-tier accounts, which can significantly increase costs.
Your system’s architecture will depend on these early decisions. Here are a few options:
- Self-hosted models: Keep PHI within your Virtual Private Cloud for maximum control.
- Hybrid de-identification: Send only de-identified data to external APIs.
- Direct cloud with BAA: Simplifies implementation but requires a high level of trust in your vendor.
Additionally, establish oversight tiers based on risk. For example:
- Tier 1: Low-risk tasks like administrative automation can run autonomously.
- Tier 2: Moderate-risk recommendations require human acknowledgment.
- Tier 3: High-risk decisions, such as clinical actions, demand full human review.
Defining these tiers upfront avoids confusion about accountability later. Align your planning with frameworks like ISO/IEC 42001 and the NIST AI Risk Management Framework to ensure your AI meets standards for safety, privacy, and accountability. This proactive approach can help you avoid compliance fines, which are projected to hit $19 billion globally by the end of 2024 [1].
Data Handling and Governance
Once the planning phase is complete, strong data governance becomes the backbone of compliance. Following HIPAA and NIST guidelines, start by masking PHI before it reaches your AI models. Using specialized Named Entity Recognition (NER) tools - like Microsoft Presidio, Amazon Comprehend Medical, or John Snow Labs - can improve accuracy compared to basic regex patterns.
Apply the "minimum necessary" principle strictly. For instance, a coding AI doesn’t need a patient’s phone number or full address; it only requires essential data like diagnosis and procedure codes. This reduces risk and aligns with HIPAA’s principles.
Immutable audit trails are also crucial. Every AI decision involving PHI should be logged in tamper-proof storage, such as S3 Object Lock, and retained for six years to meet HIPAA requirements. Logs should include details like model version, input hashes, confidence scores, and human reviewer identities.
For encryption, use envelope encryption with a Key Management Service (KMS) to separate keys from encrypted data. Implement AES-256 for data at rest and TLS 1.3 for data in transit. If using cloud AI APIs, enable zero-data-retention modes to ensure prompts and outputs aren’t stored by the vendor.
Another key measure is just-in-time unmasking. Only authorized users, such as fraud investigators, should have access to unmasked data, and every instance should be logged [8].
Be cautious about processing psychotherapy notes, which have stricter HIPAA protections. These should never be used without explicit, separate patient authorization.
Deployment and Continuous Monitoring
Deployment and monitoring are where compliance efforts are put to the test. Before going live, conduct algorithmic impact assessments as required by laws like Colorado’s SB 24-205, effective February 2026. These assessments identify risks in high-stakes AI systems and help document mitigation strategies.
Post-deployment, real-time anomaly detection can flag potential violations. AI monitoring systems can catch issues that manual reviews might miss, ensuring compliance is maintained.
Given the constant evolution of regulations - about 230 new or updated rules emerge globally every day [1] - automated tracking tools are indispensable. These tools can monitor updates to HIPAA, state privacy laws, and frameworks like NIST, adjusting your compliance protocols as needed.
Real-time dashboards can display model performance, drift detection, and compliance metrics. If a model’s outputs deviate or confidence scores drop, alerts should notify the team immediately, allowing for quick intervention and recalibration.
Prepare for data breaches with a clear response plan. This should include automated detection, notification within 60 days for breaches affecting 500 or more people, and tailored remediation steps.
Finally, establish a cross-functional oversight group that includes compliance, IT, clinical, and finance leaders. This team should regularly review audit logs, investigate anomalies, and ensure risks identified by AI are addressed through corrective actions and staff training.
As Dave Rowe from Intellias notes:
"Managing healthcare compliance is a continuous investment of time and talent... when AI is integrated into the process, it enables real-time regulatory radar for team members." [9]
With over half of healthcare compliance leaders reporting resource constraints, automation through continuous monitoring is increasingly essential to manage risks effectively [9].
Technical and Administrative Controls for Healthcare AI
Building strong technical and administrative controls from the start is critical for ensuring compliance and reducing risks in healthcare AI systems. These measures are essential for protecting patient data, adhering to HIPAA regulations, and preventing unauthorized access to AI-driven clinical tools. The stakes are high - HIPAA violations can lead to fines ranging from $100 to $50,000 per incident, with annual caps nearing $1.9 million per category. In cases of willful neglect, criminal charges may also apply [6].
Riya Arya from Daffodil Software highlights the importance of this approach:
"The organizations winning in healthcare AI are those that treat compliance as a design constraint, not a legal review step after the fact." [6]
This "compliance-by-design" philosophy ensures that robust safeguards are integrated early in the development process, rather than being treated as an afterthought.
Technical Controls: Encryption, Access Management, and Logging
Implementing strong technical controls is non-negotiable. For example, AES-256 should be used for data at rest, while TLS 1.3 secures data in transit, including API calls and internal communications. Envelope encryption with a Key Management System (KMS) separates encryption keys from data, adding an extra layer of security. Certificate pinning can also guard against man-in-the-middle attacks.
Access management plays a key role in protecting data. Role-Based Access Control (RBAC) and Multi-Factor Authentication (MFA) ensure that AI agents can only access the specific clinical data they need. Assigning each AI agent or microservice its own service account with narrowly defined permissions minimizes the risk of cross-service data leaks.
Audit logs are another essential component. These logs should capture decision IDs, model versions, input hashes (using SHA-256), confidence scores, and human review status. HIPAA mandates that logs involving Protected Health Information (PHI) be stored in tamper-proof systems, such as S3 Object Lock or Azure Immutable Blob Storage, for at least six years [2].
To further secure sensitive data, AI compute should operate within a private Virtual Private Cloud (VPC) using private endpoints like AWS PrivateLink. A PHI-scrubbing layer, powered by advanced Named Entity Recognition (NER) models tailored for clinical text, can prevent raw identifiers from being exposed to AI vendors.
Emerging threats like prompt injection require proactive measures. For instance, if an attacker manipulates an AI system to disclose PHI, it constitutes a serious breach. Similarly, fine-tuning models on raw PHI poses risks, as the models may unintentionally memorize and later reveal sensitive information.
Sagili Yashwanth Reddy, COO of BeyondScale, underscores this point:
"Every piece of data derived from PHI is itself PHI under HIPAA. Treat it accordingly."
These technical safeguards set the stage for effective oversight of third-party vendors.
Third-Party Risk Management
Managing third-party risks effectively starts with thorough vendor evaluations based on criteria like HIPAA compliance, clinical trial integrity, and security implications for medical devices. In healthcare AI, vendor assessments are particularly important for ensuring the safety of clinical research data and medical device security.
Many organizations are turning to RiskOps frameworks to streamline third-party risk management. Platforms like Censinet RiskOps™ and Censinet Connect™ simplify this process by automating security questionnaires and summarizing evidence and documentation.
Incorporating AI-specific risk evaluations into HIPAA compliance workflows ensures that PHI is securely managed by external partners. Key areas to focus on include:
- Vendors & Products: Ensuring Business Associate Agreements (BAAs) are in place and that solutions offer zero-data-retention modes.
- Medical Devices: Maintaining an updated inventory of AI-enabled devices and monitoring their security.
- Supply Chain: Identifying and assessing risks tied to subcontractors.
Censinet highlights the value of these efforts:
"Revolutionize the way your healthcare organization manages third-party and enterprise risk while also saving time, money, and increasing data security." [10]
Benchmarking studies, such as the 2026 Healthcare Cybersecurity & AI Benchmarking Study, help organizations measure their risk management practices against industry standards, making it easier to identify areas for improvement.
Strong third-party risk management complements technical safeguards, especially when securing AI-powered medical devices.
Medical Device and Endpoint Security
AI-enabled medical devices introduce unique challenges. By August 2024, the FDA had authorized 950 such devices [11]. These tools often connect to hospital networks, process PHI, and provide clinical insights, making rigorous oversight essential.
Establishing an AI governance committee is a key step. This committee should include representatives from clinical, IT, security, legal, and risk management teams to ensure shared accountability for device security.
Risk-based tiering is another effective strategy. For instance, clinical diagnostic tools generally require stricter oversight than administrative automation tools. A standardized intake process for new AI tools - covering use-case descriptions, data flow mapping, and vendor evaluations - can help organizations maintain a centralized inventory and avoid "shadow AI."
Lifecycle management is equally important. Organizations should define protocols for pilot testing, ongoing performance monitoring, updates, and decommissioning. Human-in-the-loop processes should clearly outline clinicians' roles in validating AI-generated outputs to maintain proper oversight.
Dedicated incident reporting channels are crucial for addressing issues such as model errors, bias, or unauthorized data exposure. Administrative protocols should also allow teams to disable or roll back AI systems if outcomes deviate or security measures fail.
Dr. Margaret Lozovatsky, MD, Vice President of Digital Health Innovations at the AMA, emphasizes:
"Setting up an appropriate governance structure now is more important than it's ever been because we have never seen such quick rates of adoption." [13]
Chris Harrop, Senior Editor at MGMA, adds a cautionary note:
"If your policy doesn't create a safe, approved path, staff will create their own." [12]
Without proper controls, the rapid adoption of AI can outpace an organization's ability to manage risks effectively.
Setting Up Governance Structures for AI Oversight
Managing AI risks in healthcare demands a solid governance structure. Without clear oversight, AI systems can multiply unchecked, leading to compliance issues and security risks. A well-constructed governance framework ensures that every AI system is carefully assessed, monitored, and aligned with regulations before interacting with patient data or clinical workflows. This approach makes compliance a core part of the process from the very beginning.
Creating AI Governance Committees
AI governance committees play a pivotal role by bringing together specialists from various disciplines - security, clinical care, technology, and compliance. For example:
- Security leaders, like CISOs or Deputy CISOs, craft policies for AI procurement and develop strategies to communicate risks to executive teams.
- Clinical leaders, such as physician executives and informaticists, ensure AI tools integrate safely into workflows without compromising patient care.
- Technical and AI product experts address AI-specific risks, including prompt injection attacks, model poisoning, and vulnerabilities in autonomous systems.
- Risk and policy advisors assess the organization's resilience and align security measures with operational goals.
Healthcare organizations are shifting from traditional vulnerability management to programs tailored for large language models (LLMs) and autonomous AI systems. Conventional security frameworks often fall short in addressing the unique risks posed by AI. Governance committees must prioritize monitoring threats like prompt injection and model poisoning, starting as early as the procurement phase. This early-stage evaluation helps ensure that AI technologies are thoroughly vetted before being integrated into clinical environments.
Tools like Censinet RiskOps™ simplify governance by directing critical AI assessments to the appropriate stakeholders, including committee members. This centralized system facilitates real-time tracking of AI-related risks and policies, building on established compliance frameworks. Additionally, Censinet AI™ automates tasks like vendor security questionnaires, evidence summaries, and integration tracking. These tools enable governance committees to scale their oversight efforts without compromising safety.
While these committees lay the foundation for strong policies and oversight, the next challenge lies in seamlessly weaving these controls into clinical workflows.
Balancing Security and Clinical Workflow Integration
One of the toughest challenges is safeguarding patient data without disrupting the flow of clinical work. Overly strict security measures can frustrate clinicians, potentially leading to risky workarounds. To address this, governance committees need to focus on fostering a "human-AI partnership", ensuring AI tools enhance rather than hinder clinical efficiency.
The process begins with workflow mapping to pinpoint exactly where AI systems fit into clinical routines. Engaging clinical staff in the design of security measures ensures that these controls are practical and won’t create unnecessary hurdles. Instead of a blanket approach, modular security controls can be customized for different clinical scenarios. Feedback loops, where clinicians can report any friction caused by security measures, are invaluable. Pilot testing in specific clinical areas before a full rollout also helps identify and resolve potential issues early on. Regular meetings between security and clinical teams further ensure that conflicts are addressed proactively, minimizing disruptions to patient care.
Maintaining Compliance Through Monitoring and Updates
Building compliance into AI systems from the start is just the first step. The real challenge? Keeping those systems compliant as regulations constantly shift [1]. In healthcare, compliance can't be treated as a one-and-done task. With the regulatory landscape evolving rapidly and new cybersecurity threats emerging, AI systems must adapt just as quickly. This requires ongoing risk assessments and proactive updates to stay ahead.
Regular Risk Assessments and Evidence Management
Waiting for an audit to reveal compliance gaps is a risky and often costly approach. Instead, healthcare organizations should adopt what experts call "rituals of durability" - regular reviews of regulatory changes combined with continuous monitoring of how processes adjust over time.
Automated evidence management tools can integrate with current compliance systems to ensure AI remains audit-ready. For instance, maintaining a detailed change log that tracks access and modifications can fulfill 80% of audit evidence requirements [1]. As one expert wisely put it:
"Compliance isn't about passing the audit - it's about proving you deserve your customer's trust." – Compliagence AI [1]
For AI systems, aligning with frameworks like ISO/IEC 42001, the first international standard for AI management, offers a structured path to governance, risk management, and continuous monitoring. Additionally, specialized frameworks such as the OWASP Top 10 for Large Language Model Security provide tailored guidance for addressing AI-specific vulnerabilities like prompt injection and model poisoning.
Tools like Censinet RiskOps™ simplify ongoing compliance efforts by consolidating real-time data into a centralized AI risk dashboard. This hub makes it easier to track regulatory updates, manage risks, and maintain audit-ready documentation. Meanwhile, Censinet AI™ reduces manual workload by summarizing vendor documentation and capturing integration details, streamlining evidence management for compliance teams.
Incident Response and Remediation
Beyond regular assessments, healthcare organizations must also prepare for AI-specific incidents. Traditional incident response plans often fall short when dealing with threats like model poisoning or the risks posed by autonomous "agentic AI", which some experts now view as a new type of insider threat.
Effective incident response protocols need to address these unique challenges without jeopardizing patient safety. This means setting up clear escalation paths for AI-related incidents and defining workflows for remediation that balance technical fixes with uninterrupted clinical care. Including members from AI governance committees - such as clinical informaticists and cybersecurity experts - ensures that remediation efforts are both technically sound and clinically viable.
Tracking remediation efforts through platforms like Censinet RiskOps™ allows organizations to document findings, assign accountability, and systematically resolve incidents. This approach strengthens the broader compliance framework while ensuring patient care remains a top priority.
With non-compliance fines projected to hit approximately $19 billion by the end of 2024 [1], the stakes are high. Organizations that treat compliance as an ongoing process, rather than a periodic task, are better equipped to adapt to regulatory changes and maintain the trust of patients, partners, and regulators alike.
Conclusion
In healthcare AI, compliance is no longer optional or something to address later. The fast-and-loose approach of "move fast and break things" has given way to a new mantra: regulation by design [14]. Organizations that weave governance frameworks into their operations from the beginning sidestep the pitfalls of "compliance debt." This debt - marked by rushed policies, incomplete documentation, and technical shortcuts - only leads to audit headaches and eroded trust.
But this isn’t just about avoiding penalties. With non-compliance fines expected to hit $19 billion by the end of 2024 and over 230 new regulations introduced globally every day [1], the stakes are higher than ever. Taking a proactive approach to compliance builds what experts call a "trust moat" - a competitive edge that reassures patients, providers, and investors that your organization is serious about managing risk [1].
Starting with compliance also means establishing practical, audit-ready systems that protect patient data and ensure smooth scaling. For example, defining your AI tool’s classification under FDA guidelines lays out its regulatory path. Implementing human-in-the-loop workflows, leveraging transparent technologies like Retrieval-Augmented Generation (RAG), and aligning with global standards such as ISO/IEC 42001 help organizations grow without needing to dismantle and rebuild processes later [1][14].
Jeff Ward, Partner at Aprio, highlights the strategic value of this approach:
"Effective compliance isn't about checking boxes when auditors arrive - it's about building audit-ready processes from day one. The organizations that succeed are those that view third-party validation as a strategic advantage, not a necessary evil" [1].
In a field where patient safety and data security meet rapid technological advancements, governance isn’t a hindrance - it’s the bedrock for sustainable progress. Healthcare organizations must now confront a critical question: can they afford not to make compliance a priority? Only those that govern with intention will secure the trust needed to innovate responsibly in healthcare.
FAQs
Does my healthcare AI use PHI?
Proper management of Protected Health Information (PHI) is crucial when your healthcare AI processes or handles patient data. This includes careful attention to how PHI is retained and disposed of. These steps are essential for staying compliant with HIPAA regulations and safeguarding sensitive data.
When do I need a BAA for AI vendors?
A Business Associate Agreement (BAA) is required when AI vendors manage protected health information (PHI) for healthcare organizations. This agreement ensures adherence to HIPAA regulations and reduces legal risks associated with handling PHI.
What should I log for HIPAA-ready AI?
To keep AI systems in line with HIPAA regulations, it's crucial to log all activities related to protected health information (PHI). This includes automated decisions, data access events, disclosures, and any system actions involving PHI. Detailed audit trails are a must - they not only ensure transparency but also help meet compliance requirements.
